AIM ImmunoTech Inc. (AIM) Capital expenditures 2016–2025
AIM ImmunoTech Inc. (AIM) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$18,000FY2025 · since FY2016: $240,000 → $18,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $18,000 | — |
| FY2023 | $86,000 | +109.8% |
| FY2022 | $41,000 | +86.4% |
| FY2021 | $22,000 | -67.6% |
| FY2020 | $68,000 | +33.3% |
| FY2019 | $51,000 | +155.0% |
| FY2018 | $20,000 | -87.5% |
| FY2017 | $160,000 | -33.3% |
| FY2016 | $240,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice